Skip to main content
. 2021 Jul 8;13(14):3435. doi: 10.3390/cancers13143435
aCT Adjuvant chemotherapy
aCRT Adjuvant chemoradiotherapy
aRT Adjuvant radiotherapy
CCRT Concomitant chemoradiotherapy
CI Confidence interval
CONSORT Consolidated Standards of Reporting Trials
DSS Disease-specific survival
ECS Extra capsular spread
EORTC European Organization for Research and Treatment of Cancer
5-FU 5-fluorouracil
HR Hazard ratio
IC Induction chemotherapy
ICRT Induction chemoradiotherapy
KM Kaplan–Meier
LP Larynx preservation
LEDFS Laryngo-esophageal dysfunction-free survival
LFS Laryngectomy-free survival
LPFRS Larynx Preservation Failure Risk Score
n.a. Not available
n.s. Not significant
NCDB National Cancer Data Base
OPL Open partial laryngectomy
OS Overall survival
pCRT Primary chemoradiotherapy
p(C)RT Primary radiotherapy or primary chemoradiotherapy
pRT Primary radiotherapy
QoL Quality of life
R+ Positive resection margin
SFX Standard fractionation
TDRS Total Dysphagia Risk Score
TLM Transoral laser microsurgery
TL Total laryngectomy
TPF Docetaxel, cisplatin, 5-FU (an induction chemotherapy regimen)
TNM Staging according to T = primary tumor, n = lymph node metastases, and M = distant metastases
rTNM TNM of recurrent tumors
UICC Union International Contre le Cancer (International Union against Cancer